Evidence map›Paper›PMID 30081500›Full record

Trial reportNutrients2018

Effects of Magnesium Supplementation on Unipolar Depression: A Placebo-Controlled Study and Review of the Importance of Dosing and Magnesium Status in the Therapeutic Response.

Beata Ryszewska-Pokraśniewicz, Anna Mach, Michał Skalski, Piotr Januszko, Zbigniew M Wawrzyniak, Ewa Poleszak, Gabriel Nowak, Andrzej Pilc, Maria Radziwoń-Zaleska

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Investigations on Potential Applications of CaMg(COMolecules (Basel, Switzerland) · 2022
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Beata Ryszewska-PokraśniewiczNowowiejski Hospital, 00-685 Warsaw, Poland. beataryszewska@wp.pl.
Anna MachDepartment of Psychiatry, Medical University of Warsaw, 00-685 Warsaw, Poland. anna.mach@wum.edu.pl.
Michał SkalskiDepartment of Psychiatry, Medical University of Warsaw, 00-685 Warsaw, Poland. michal.skalski@wum.edu.pl.
Piotr JanuszkoDepartment of Psychiatry, Medical University of Warsaw, 00-685 Warsaw, Poland. piotr.januszko@wp.pl.
Zbigniew M WawrzyniakFaculty of Electronics and Information Technology, Warsaw University of Technology, 00-685 Warsaw, Poland. z.wawrzyniak@ise.pw.edu.pl.ORCID 0000-0003-0052-4114
Ewa PoleszakFaculty of Pharmacy, Medical University of Lublin, 20-093 Lublin, Poland. ewa.poleszak@umlub.pl.
Gabriel NowakInstitute of Pharmacology, Polish Academy of Sciences, 31-343 Kraków, Poland. nowak@if-pan.krakow.pl.
Andrzej PilcInstitute of Pharmacology, Polish Academy of Sciences, 31-343 Kraków, Poland. nfpilc@cyf-kr.edu.pl.
Maria Radziwoń-ZaleskaDepartment of Psychiatry, Medical University of Warsaw, 00-685 Warsaw, Poland. mariar@wum.edu.pl.
Medical University of Warsaw · PLMaj Institute of Pharmacology · PLMedical University of Lublin · PLWarsaw University of Technology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Animal studies using tests and models have demonstrated that magnesium exerts an antidepressant effect. The literature contains few studies in humans involving attempts to augment antidepressant therapy with magnesium ions. The purpose of our study was to assess the efficacy and safety of antidepressant treatment, in combination with magnesium ions. A total of 37 participants with recurrent depressive disorder who developed a depressive episode were included in this study. As part of this double-blind study, treatment with the antidepressant fluoxetine was accompanied with either magnesium ions (120 mg/day as magnesium aspartate) or placebo. During an 8-week treatment period, each patient was monitored for any clinical abnormalities. Moreover, serum fluoxetine and magnesium levels were measured, and pharmaco-electroencephalography was performed. The fluoxetine + magnesium and fluoxetine + placebo groups showed no significant differences in either Hamilton Depression Rating Scale (HDRS) scores or serum magnesium levels at any stage of treatment. Multivariate statistical analysis of the whole investigated group showed that the following parameters increased the odds of effective treatment: lower baseline HDRS scores, female gender, smoking, and treatment augmentation with magnesium. The parameters that increased the odds of remission were lower baseline HDRS scores, shorter history of disease, the presence of antidepressant-induced changes in the pharmaco-EEG profile at 6 h after treatment, and the fact of receiving treatment augmented with magnesium ions. The limitation of this study is a small sample size.

Indexed as

Dietary SupplementsAdultAffectAgedAntidepressive Agents, Second-GenerationAspartic AcidDepressive DisorderDouble-Blind MethodFemaleFluoxetineHumansMaleMiddle AgedPolandRemission InductionSelective Serotonin Reuptake InhibitorsAntidepressive Agents, Second-GenerationAspartic AcidFluoxetineSelective Serotonin Reuptake Inhibitorsefficacymagnesiumpharmaco-electroencephalographyremissionunipolar depression

Identifiers

PMID30081500
PMCPMC6115747
OpenAlexW2886411895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.